Energy Expenditure In Obese Women Research Articles

Does diet and activity lead to difference in resting energy expenditure in obese women?

BackgroundObesity is considered as a risk factor for metabolic and chronic diseases. Reduction in resting energy expenditure (REE) may increase risk of obesity. Our study was carried out to investigate dietary, biochemical, anthropometric and body composition parameters and physical activity in obese women with normal and low resting energy expenditure.MethodsA total forty nine subjects (women, 30-50 years old) were enrolled and divided into three groups. Anthropometric, body composition parameters, resting energy expenditure, Fasting blood lipid profile, dietary intake and physical activity were measured.ResultsAlthough, fat mass and fat-free mass were significantly increased in obese groups, there was no significant difference in body composition between two obese groups (p-value = 0.10, 0.27). Measured resting energy expenditure was significantly decreased in obese with low REE compare to other groups (p-value < 0.001). There was no significant difference in energy intake and macronutrients between groups. There was a significant difference in T3 between obese subjects with low REE compared to obese group with normal REE (p-value < 0.001). There was no significant difference in lipid profile between two obese groups. Also there was a significant difference in LDL, cholesterol and triacylglycerol between obese subjects with low REE compared to normal weight group. Moreover, there was a significant difference in cholesterol and triacylglycerol between obese subjects with normal REE compared to normal weight group. Our finding showed there was no significant difference in physical activity between three groups.ConclusionsDietary intake and physical activity may relate to metabolism and energy expenditure. It is interesting that in some obese people resting energy expenditure was much lower compared to other obese people; however, there was no significant difference in their body composition, age, sex, dietary intake, lipid profile and physical activity. Thus it should investigate the role of other factors involved in different REE in subjects with obesity.

Obese Women With Hypothyroidism Treated with Levothyroxine Have Reduced Resting Energy Expenditure

Obese Women With Hypothyroidism Treated with Levothyroxine Have Reduced Resting Energy Expenditure

Resting Energy Expenditure in Obese Women with Primary Hypothyroidism and Appropriate Levothyroxine Replacement Therapy.

Growing evidence suggests that appropriate levothyroxine (LT4) replacement therapy may not correct the full set of metabolic defects afflicting individuals with hypothyroidism. To assess whether obese subjects with primary hypothyroidism are characterized by alterations of the resting energy expenditure (REE). Retrospective analysis of a set of data about obese women attending the outpatients service of a single obesity center from January 2013 to July 2019. A total of 649 nondiabetic women with body mass index (BMI) > 30 kg/m2 and thyrotropin (TSH) level 0.4-4.0 mU/L were segregated into 2 groups: patients with primary hypothyroidism taking LT4 therapy (n = 85) and patients with normal thyroid function (n = 564). REE and body composition assessed using indirect calorimetry and bioimpedance. REE was reduced in women with hypothyroidism in LT4 therapy when compared with controls (28.59 ± 3.26 vs 29.91 ± 3.59 kcal/kg fat-free mass (FFM)/day), including when adjusted for age, BMI, body composition, and level of physical activity (P = 0.008). This metabolic difference was attenuated only when adjustment for homeostatic model assessment of insulin resistance (HOMA-IR) was performed. This study demonstrated that obese hypothyroid women in LT4 therapy, with normal serum TSH level compared with euthyroid controls, are characterized by reduced REE, in line with the hypothesis that standard LT4 replacement therapy may not fully correct metabolic alterations related to hypothyroidism. We are not able to exclude that this feature may be influenced by the modulation of insulin sensitivity at the liver site, induced by LT4 oral administration.

UCP2, SHBG, Leptin, and T3 Levels are Associated with Resting Energy Expenditure in Obese Women.

The aim of this study was to investigate the association of Sex Hormone Binding Globulin (SHBG) with leptin, Triidothyronine (T3), and Uncoupling Protein 2 (UCP2) in obese women with low and normal Resting Energy Expenditure (REE) and to determine the role of these factors in the regulation of REE in obese women. A total 49 subjects (25-50 years old) were selected. Anthropometric and body composition parameters and resting energy expenditure were measured. Fasting circulating leptin, T3, SHBG and UCP2 levels were measured. Subjects were divided into three groups: Group І (BMI>30 and low resting energy expenditure, 16 subjects), group II (BMI>30 and normal resting energy expenditure, 17 subjects), and group ІІІ (control group, 16 non-obese subjects). It was found that obese subjects who had higher SHBG and leptin levels were at risk for high levels of UCP2. A significant association was found between T3 and REE. Obese subjects with higher concentrations of UCP2 and SHBG had decreased resting energy expenditure. A significant association was observed between SHBG and leptin in group І (r=0.90, p<0.0001) and group ІІ (r=0.83, p<0.0001). Moreover, a significant association was found between T3 and SHBG in group І (r=-0.69, P=0.003). Changes of the UCP2, leptin, and thyroid hormone (T3) levels may be related to SHBG levels. Thus, lower leptin and T3 levels may decrease SHBG in obese women. Therefore, lower SHBG, leptin, T3 and UCP2 levels may decrease the REE level in obese women.

The hyperleptinemia state can downregulate cardiorespiratory fitness and energy expenditure in obese women

IntroductionIn general, in obese people a state of hyperleptinemia may impair both energy balance and the inflammatory process. However, it has not been fully investigated whether there is a relationship between hyperleptinemia and cardiorespiratory fitness (CRF) and resting energy expenditure (REE), in obese women. Methods83 obese women were enrolled in this cross-sectional study. Anthropometric measures, body composition, REE, CRF and serum concentration of leptin were measured. Pearson's correlation coefficient was performed to examine the relationship between circulating leptin level and other clinical variables. Multiple regression analysis was applied to determine predictors of REE and CRF. Effects were considered significant at p≤0.05. ResultsThe most important finding in the present study is that the hyperleptinemia state was inversely correlated with CRF (r=−0.382, p=0.001) and REE (r=−0.447, p<0.001). Moreover, a positive correlation with fat mass was confirmed (r=0.419, p<0.001). In addition, hyperleptinemia was an independent negative predictor of REE (r2=−2.649, p=0.010) and CRF (r2=−2.335, p=0.023). ConclusionTogether our results may suggest a vicious cycle between the state of hyperleptinemia and a decrease in energy expenditure and cardiorespiratory fitness in obese women, which can impair whole body energy homeostasis. This information is important to contribute to clinical practices.

Association between uncoupling protein 2, adiponectin and resting energy expenditure in obese women with normal and low resting energy expenditure

Obesity is recognized as the most prevalent metabolic disease worldwide. Decreases in energy expenditure may increase risk of obesity. One of the key regulators of energy balance is uncoupling protein2 (UCP2), a transporter protein presents in mitochondrial inner membrane. Moreover, adiponectin is the most abundant adipocytokine, it may play a role in energy metabolism and gene expression of UCP2. The aim of this study was to investigate potential associations between the level of uncoupling protein 2 and adiponectin and their relationship with REE (Resting Energy Expenditure) in obese women with normal and low resting energy expenditure. A total of 49 subjects (women, 25–50 years old), were included in current study, 16 subjects with BMI > 30 and low resting energy expenditure, 17 subjects with BMI > 30 and normal resting energy expenditure and 16 non-obese subjects as a control group. Anthropometric, body composition parameters and resting energy expenditure were measured. Plasma adiponectin, UCP2 protein and total protein in PBMC were determined. Measured resting energy expenditure in obese subjects with low REE was significantly lower than other groups. Plasma adiponectin in the obese subjects with low REE was significantly lower compared to normal weight group. There was a significant relationship between ‘UCP2 protein/Total protein’ ratio and plasma adiponectin in obese group with low REE and in three groups when we pooled. There was a significant association between REE and plasma adiponectin in three groups when we pooled. There was a significant association between plasma adiponectin and REE. Moreover, there was a significant relationship between UCP2 and REE.

Environmental factors and beta2-adrenergic receptor polymorphism: influence on the energy expenditure and nutritional status of obese women.

Our aim was to evaluate the influence of the Gln27Glu polymorphism of the β2-adrenergic receptor (ADRβ2) gene, fat intake and physical activity on the energy expenditure (EE) and nutritional status of obese women. Sixty obese women (30-46years) participated in the study and were assigned to three groups depending on the genotypes: Gln27Gln, Gln27Glu and Glu27Glu. At baseline and after nutritional intervention, the anthropometric and body composition (bioelectrical impedance), dietary, EE (indirect calorimetry) and biochemical variables were measured. All women received a high-fat test meal to determine the postprandial EE (short-term) and an energy-restricted diet for 10weeks (long term). The frequencies of Gln27Gln, Gln27Glu and Glu27Glu were 36.67, 40.0 and 23.33%, respectively. Anthropometric and biochemical variables and EE did not differ between groups, although women who had no polymorphism demonstrated decreased carbohydrate oxidation. On the other hand, the Glu27Glu genotype showed a positive relation with EE in physical activity and fat oxidation. The environmental factors and Gln27Glu polymorphism did not influence the nutritional status and EE of obese women, but physical activity in obese women with the polymorphism in the ADRβ2 gene can promote fat oxidation. The results suggest that encouraging the practice of physical exercise is important considering the high frequency of this polymorphism in obese subjects.

Eating more quickly heightens overall systemic exposure to glucose and NEFA in the post-prandial phase, irrespective of energy expenditure in obese women

Eating more quickly heightens overall systemic exposure to glucose and NEFA in the post-prandial phase, irrespective of energy expenditure in obese women

Does stride length influence metabolic cost and biomechanical risk factors for knee osteoarthritis in obese women?

Background Obesity is the primary modifiable risk factor for knee osteoarthritis. The goal of this study was to develop a walking protocol for obese individuals that supported weight loss while minimizing biomechanical risk factors for knee osteoarthritis. We tested the hypotheses that walking with short, quick strides at a preferred walking speed requires more energy expenditure in obese women and reduces biomechanical risk factors for knee osteoarthritis at foot–ground impact relative to walking at the preferred stride length. Methods Ten obese (BMI = 33.09(4.22) kg/m 2) and 10 healthy-weight (BMI = 22.66(0.86) kg/m 2) women volunteered. V ˙ O 2 was measured while subjects walked on a treadmill at their preferred walking speed at a preferred stride length and a 15% shortened stride length (increased stride frequency). Peak impact shock, peak external knee adduction moment, and knee adduction angular impulse were measured during the two gait conditions. Findings Decreasing stride length 15% significantly increased metabolic cost by 4.6% ( P < 0.01; effect size = 0.24) and decreased the adduction angular impulse ( P = 0.046; effect size = 0.203), but did not significantly affect the adduction moment ( P = 0.196; effect size = 0.100) or impact shock ( P = 0.698; effect size = 0.605). Interpretation The small, but significant, increase in metabolic cost when walking with short, quick steps may be beneficial for weight reduction or maintenance in obese populations. The results of this study suggest that a 15% decrease in stride length is not sufficient to decrease the peak values of two of the biomechanical variables that may predispose obese women to knee osteoarthritis but does elicit benefits over the course of a stride.

Poor prediction of resting energy expenditure in obese women by established equations

The objective of the study was to evaluate the accuracy of established prediction equations that calculate resting energy expenditure (REE) in obese women. This was a cross-sectional study. In 273 mildly to severely obese women (age, 41.7 ± 13.2 years; body mass index, 42.8 ± 7.0 kg/m 2), REE was measured by indirect calorimetry (mREE), along with fat mass (FM) and fat-free mass (FFM) by bioelectrical impedance analysis. Eleven established equations were used to predict REE (pREE), with 9 equations basing on the anthropometric parameters body weight and height and 2 equations including body composition parameters (FM, FFM). All equations provided pREE values that significantly correlated with mREE ( r > 0.66, P < .001), although 8 equations systematically underestimated mREE ( P < .05). Of note, even the best equation was not able to accurately predict mREE with a deviation of less than ±10% in more than 70% of the tested women. Furthermore, equations using body composition data were not superior in predicting REE as compared with equations exclusively including anthropometric variables. Multiple linear regression analyses revealed 2 new equations—one including body weight and age and another including FM, FFM, and age—that explained 56.9% and 57.2%, respectively, of variance in mREE. However, when these 2 new equations were applied to an independent sample of 33 obese women, they also provided an accurate prediction (±10%) of mREE in only 56.7% and 60.6%, respectively, of the women. Data show that an accurate prediction of REE is not feasible using established equations in obese women. Equations that include body composition parameters as assessed by bioelectrical impedance analysis do not increase the accuracy of prediction. Based on our results, we conclude that calculating REE by standard prediction equations does not represent a reliable alternative to indirect calorimetry for the assessment of REE in obese women.

The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women

Given the suggestion that many potential anti-obesity drugs may enhance within-meal satiation, few studies have directly measured the effects of any drug on the microstructure of human eating behaviour. The effects of 7 days dosing with sibutramine 10 mg and 15 mg a day on appetite and energy balance were determined in 30 obese women (BMI 34.6 +/- 3.3 kg/m2, age 46.0 +/- 12.9 years) using a Universal Eating Monitor (UEM) and indirect calorimetry, in a double-blind, placebo-controlled crossover study. At day 7, sibutramine 10 mg and 15 mg reduced food intake by 16.6% and 22.3%, respectively (p < 0.001), compared with placebo. Sibutramine reduced eating rate compared with placebo rather than meal length (10 mg p < 0.05; 15 mg p < 0.001). In addition, sibutramine 10 mg significantly reduced hunger later in the meal (p < 0.05) and sibutramine 15 mg increased fullness early in the meal (p < 0.01), both of which are consistent with enhanced within-meal satiation. Sibutramine had little effect on resting metabolic rate, although 15 mg did significantly reduce respiratory quotient at several time points during the test day. These results provide novel evidence that decreased consumption of a test meal induced by sibutramine is primarily because of reduced eating rate, enhancing the deceleration in cumulative food intake within a meal associated with the development of satiety. Changes in within-meal appetite ratings appear particularly sensitive to drug-induced enhancement of satiation, and may provide key indices for assessing the therapeutic potential of novel anti-obesity drugs.

A Comparison of Calculated and Measured Resting Energy Expenditure in Obese Women

Resting energy expenditure (REE) measured using indirect calorimetry was compared with REE calculated with the Harris-Benedict equation (HBE) using actual (ABW), ideal (IBW), and adjusted (AdjBW) body weight and with the Ireton-Jones Equation (IJE) in 19 obese females. Root mean square prediction error (RMSPE) analysis indicated that HBE using IBW and AdjBW were the most accurate predictors of measured REE. T test revealed no significant difference between HBE using IBW and measured REE. The IJE and HBE, using ABW and AdjBW, were significantly higher than measured REE. In conclusion, HBE using IBW or AdjBW is better than HBE using actual weight or IJE for estimating REE in obese women.

Measured Vs. Predicted Basal Energy Expenditure in Obese Women

The purpose of this study was to determine if actual, ideal, or adjusted body weight should be used in the Harris-Benedict equation (HBE) to estimate basal energy expenditure (BEE) in obese females and to determine if the Ireton-Jones equation (IJE) accurately estimates BEE in obese females. Nineteen healthy, premenopausal, obese (>125% IBW) females, ages 18-39 completed a questionnaire detailing demographic and medical history information. BEE was determined by open-circuit indirect calorimetry, and weight, height, and body composition (bioelectrical impedance) were measured. BEE was calculated using the HBE with ideal body weight (IBW), actual body weight (ABW) and adjusted body weight (AdBW). The mean BMI and percent body fat of subjects were 35.5+8.4 and 41.2+5.0, respectively. There was no difference (p<0.05) between measured BEE (1359±252 kcalories) and BEE calculated with HBE using IBW (1416±50). BEEs calculated with HBE using ABW (1755±218) and AdBW (1416±50) were significantly higher than measured BEE, as was calculated with IJE (1869±257). When mildly obese (Class I) subjects were dropped from the analysis, BEE by HBE using AdBW was no longer different from measured BEE. BEE was significantly (P<0.05) correlated with all predicted BEEs except for the BEE predicted with HBW using IBW. In conclusion, the HBE using IBW is the best equation to predict BEE in mildly (Class I) obese women, but HBE using AdBW is better for women with Class II or greater obesity. Equations specific for the obese population, categorized by degree of obesity, need to be developed.

Total and resting energy expenditure in obese women reduced to ideal body weight.

Obesity could be due to excess energy intake or decreased energy expenditure (EE). To evaluate this, we studied 18 obese females (148 +/- 8% of ideal body weight [IBW], mean +/- SD) before and after achieving and stabilizing at IBW for at least 2 mo and a control group of 14 never obese females (< 110% of IBW or < 30% fat). In the obese, reduced obese, and never obese groups, the percent of body fat was 41 +/- 4%, 27 +/- 4%, and 25 +/- 3%; total energy expenditure (TEE) was 2704 +/- 449, 2473 +/- 495, and 2259 +/- 192 kcal/24 h; while resting metabolic rate was 1496 +/- 169, 1317 +/- 159, and 1341 +/- 103 kcal/24 h, respectively. 15 obese subjects who withdrew from the study had a mean initial body composition and EE similar to the subjects who were successful in achieving IBW. In 10 subjects followed for at least one year after stabilizing at IBW there was no significant relationship between the deviation from predicted TEE at IBW and weight regain. These studies indicate that, in a genetically heterogeneous female population, neither the propensity to become obese nor to maintain the obese state are due to an inherent metabolic abnormality characterized by a low EE.

Energy expenditure in obese women before and during weight loss, after refeeding, and in the weight-relapse period

In 10 moderately obese women, 24-h energy expenditure (24EE) was measured in a respiration chamber under four conditions: 1) before weight loss (body weight = 77.9 kg), 2) during weight loss (63.9 kg), 3) after realimentation (62.5 kg), and 4) 6-15 mo after the study diet with ad libitum diet (67.7 kg). The 14 +/- 8 kg (mean +/- SD) weight loss produced a decrease in 24EE of 1498 +/- 1138 kJ/d (P < 0.001), ie, a decrease of weight of 107 kJ.kg body wt-1.d-1. The subsequent 24EE (conditions 3 and 4) remained lower than the value before weight loss. A significant correlation was found between changes before and after weight regain in basal respiratory quotient (RQ) and the spontaneous rate of body-weight gain after cessation of the period of low energy intake (r = 0.89, P < 0.01); this suggests that the value of the postabsorptive RQ may be a predictor of relapse of weight gain. After discontinuation of the low energy diet, an elevated postabsorptive RQ shows that the endogenous lipid oxidation is low, a condition favoring weight gain.

High levels of energy expenditure in obese women

High levels of energy expenditure in obese women

High levels of energy expenditure in obese women.

Total free living energy expenditure was compared in lean and obese women by the new doubly labelled water method and partitioned into basal metabolism and thermogenesis plus activity by whole body calorimetry. Average energy expenditure was significantly higher in the obese group (10.22 versus 7.99 MJ/day (2445 versus 1911 kcal/day); p less than 0.001) resulting from an increase in the energy cost of both basal metabolism and physical activity. Self recorded energy intakes were accurate in the lean subjects but underestimated expenditure by 3.5 MJ/day (837 kcal/day) in the obese group. Basal metabolic rate and energy expenditure on thermogenesis plus activity were identical in the two groups when corrected for differences in fat free mass and total body mass. In the obese women in this series there was no evidence that their obesity was caused by a metabolic or behavioural defect resulting in reduced energy expenditure.

Energy expenditure and postprandial thermogenesis in obese women before and after weight loss

In six young obese women (mean weight 85 ± 3 kg) with a childhood history of obesity, and in six young nonobese women (mean weight 55 ± 2 kg), the energy expenditure was measured during 24 h in a respiratory chamber with a maintenance energy intake. The next day, the thermogenic response to a mixed meal was investigated by using an open circuit indirect calorimetry hood system. In addition, five of the same obese women were similarly studied after a mean weight loss of 12.1 kg (14% of initial body weight) consecutive to an 11-wk hypocaloric diet (protein-supplemented modified fast). Expressed in absolute terms, the total 24 h and basal energy expenditures were found to be significantly greater in the obese (2208 ± 105 and 1661 ± 56 kcal/24 h, respectively) than in the controls (1746 ± 61 and 1230 ± 40 kcal/24 h, respectively). After weight loss, both the total 24-h and the basal energy expenditures were significantly reduced (2009 ± 99 kcal/24 h and 1423 ± 43 kcal/24 h respectively), but both values were still greater than that of the control subjects. The thermogenic response to the mixed meal (a liquid diet containing 17, 54, and 29% as protein, carbohydrate, and lipid calories, respectively, and an energy level determined to cover 60% of the basal energy expenditure computed for 24 h) was found to be significantly reduced in the obese as compared to controls (ie, 7.6 ± 0.4% versus 9.5 ± 0.4% of the energy content of the load, respectively, p < 0.025). After weight loss, the postprandial thermogenesis of the obese was still markedly reduced (ie, 6.2 ± 0.8%). Both before and after weight loss, the relative increase in diurnal urinary norepinephrine excretion was found to be lower in the obese than in controls, when compared to the nocturnal values. These results show that the greater 24 h energy expenditure of obese women is entirely due to their higher basal metabolic rate. The lower thermogenic response to the meal in the obese supports the concept of a thermogenic defect which can favor energy gain; furthermore, the unchanged response after weight loss in the obese suggests that the thermogenic defect may be a cause rather than a consequence of obesity.

Energy expenditure of obese women during weight loss

Energy expenditure of obese women during weight loss